445 related articles for article (PubMed ID: 30690602)
1. A review of innate and adaptive immunity to coccidioidomycosis.
Hung CY; Hsu AP; Holland SM; Fierer J
Med Mycol; 2019 Feb; 57(Supplement_1):S85-S92. PubMed ID: 30690602
[TBL] [Abstract][Full Text] [Related]
2. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
[TBL] [Abstract][Full Text] [Related]
3. Host-Pathogen Interactions in Coccidioidomycosis: Prognostic Clues and Opportunities for Novel Therapies.
Krogstad P; Johnson R; Garcia-Lloret MI; Heidari A; Butte MJ
Clin Ther; 2019 Oct; 41(10):1939-1954.e1. PubMed ID: 31648806
[TBL] [Abstract][Full Text] [Related]
4. The Rise of
Van Dyke MCC; Thompson GR; Galgiani JN; Barker BM
Front Immunol; 2019; 10():2188. PubMed ID: 31572393
[TBL] [Abstract][Full Text] [Related]
5. A vaccine against coccidioidomycosis is justified and attainable.
Cole GT; Xue JM; Okeke CN; Tarcha EJ; Basrur V; Schaller RA; Herr RA; Yu JJ; Hung CY
Med Mycol; 2004 Jun; 42(3):189-216. PubMed ID: 15283234
[TBL] [Abstract][Full Text] [Related]
6. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
[TBL] [Abstract][Full Text] [Related]
7. Coccidioidomycosis: a reemerging infectious disease.
Kirkland TN; Fierer J
Emerg Infect Dis; 1996; 2(3):192-9. PubMed ID: 8903229
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.
Nguyen C; Barker BM; Hoover S; Nix DE; Ampel NM; Frelinger JA; Orbach MJ; Galgiani JN
Clin Microbiol Rev; 2013 Jul; 26(3):505-25. PubMed ID: 23824371
[TBL] [Abstract][Full Text] [Related]
9. Immune Response to Coccidioidomycosis and the Development of a Vaccine.
Castro-Lopez N; Hung CY
Microorganisms; 2017 Mar; 5(1):. PubMed ID: 28300772
[TBL] [Abstract][Full Text] [Related]
10. Coccidioidomycosis.
Stockamp NW; Thompson GR
Infect Dis Clin North Am; 2016 Mar; 30(1):229-46. PubMed ID: 26739609
[TBL] [Abstract][Full Text] [Related]
11. Progress Toward a Human Vaccine Against Coccidioidomycosis.
Cole GT; Hurtgen BJ; Hung CY
Curr Fungal Infect Rep; 2012 Dec; 6(4):235-244. PubMed ID: 23585916
[TBL] [Abstract][Full Text] [Related]
12. Differences in Host Innate Responses among Coccidioides Isolates in a Murine Model of Pulmonary Coccidioidomycosis.
Lewis ER; David VR; Doyle AL; Rajabi K; Kiefer JA; Pirrotte P; Barker BM
Eukaryot Cell; 2015 Oct; 14(10):1043-53. PubMed ID: 26275879
[TBL] [Abstract][Full Text] [Related]
13. Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.
Hurtgen BJ; Hung CY
Methods Mol Biol; 2017; 1625():45-64. PubMed ID: 28584982
[TBL] [Abstract][Full Text] [Related]
14. Coccidioidomycosis.
Bays DJ; Thompson GR
Infect Dis Clin North Am; 2021 Jun; 35(2):453-469. PubMed ID: 34016286
[TBL] [Abstract][Full Text] [Related]
15. Coccidioides immitis and posadasii; A review of their biology, genomics, pathogenesis, and host immunity.
Kirkland TN; Fierer J
Virulence; 2018; 9(1):1426-1435. PubMed ID: 30179067
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary coccidioidomycosis.
Thompson GR
Semin Respir Crit Care Med; 2011 Dec; 32(6):754-63. PubMed ID: 22167403
[TBL] [Abstract][Full Text] [Related]
17. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.
Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
Infect Immun; 2006 Jan; 74(1):516-27. PubMed ID: 16369008
[TBL] [Abstract][Full Text] [Related]
18. Host Response to
Diep AL; Hoyer KK
Front Cell Infect Microbiol; 2020; 10():581101. PubMed ID: 33262956
[TBL] [Abstract][Full Text] [Related]
19. Coccidioidomycosis: host response and vaccine development.
Cox RA; Magee DM
Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
[TBL] [Abstract][Full Text] [Related]
20. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
